Cytodyn Inc Leronlimab For COVID-19 Coronavirus Treatment Transcript
Good afternoon, everybody, and welcome to Wall Street Reporter's Next Super Stock livestream for today, May 1, 2020. We have another special presentation today from CytoDyn, the stock many of you have been following since they first presented at our live stream back in August. The stock is up tremendously, making new highs every day this week.
And today, we're going to find out what's going to be next for the company, and if this is just the start of even bigger things to come. So, we're going to have Dr. Bruce Patterson joining; we have, of course, Dr. Nader Pourhassan, the COE. And we have a lot of questions that came in. We have, I think, over 200 questions that just came in from people who have registered up until this morning. So hopefully, we'll get to address part of them. So, again [forward] is going to be simple; Nader is going to present; then we'll turn over I think to Bruce; and we'll open up for Q&A.
So with that said, Nader, I will turn it over to you.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
